Parliament Workbench
Data: Motions & questions to 26 Nov 2026 · Votes to 18 Nov 2026

Standard Motion · S2M-05218 · Session 2

Relief from Early Stages of Alzheimer's

Lodged by Michael Matheson SNP Lodged 22 Nov 2006 27 supporters

The motion

That the Parliament notes with regret the decision of the National Institute of Health and Clinical Excellence not to recommend that drugs such as Aricept, used to treat Alzheimer’s disease, are made available for wider use, and calls on the Scottish Executive and NHS Quality Improvement Scotland not to subscribe to this decision which would restrict access to drugs that have been shown to slow the effects of Alzheimer’s disease in its early stages.

Signatures by party

27 MSPs besides the lodger · 15 from other parties
SNP 12Green 4SSP 3Con 2Ind 2LD 2Sol 1SSCUP 1

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

27 MSPs

SNP 12 Green 4 SSP 3 Con 2 Ind 2 LD 2 Sol 1 SSCUP 1

Show all 27 supporters by party

SNP 12

Green 4

SSP 3

Con 2

Ind 2

LD 2

Sol 1

SSCUP 1

Party shown is each supporter’s party when the motion was published.

In the Official Report

No contribution in the Official Report cites S2M-05218 by reference.